00-046
Phase 3 Completed
4,952 enrolled
GRECCAR8
Phase 3 Completed
5 enrolled
MTM-COLON-II
Phase 3 Completed
21 enrolled
RIFIONA
Phase 3 Completed
320 enrolled
FIDURA
Phase 3 Completed
354 enrolled
Néofirinox
Phase 3 Completed
461 enrolled
COLORII
Phase 3 Completed
1,044 enrolled
GRECCAR12
Phase 3 Completed
218 enrolled
NACRE
Phase 3 Completed
103 enrolled
Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Phase 3 Completed
572 enrolled
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Phase 3 Completed
500 enrolled
GASVERT
Phase 3 Completed
744 enrolled
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
Phase 3 Completed
463 enrolled 17 charts
ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Phase 3 Completed
1,010 enrolled 22 charts
GRECCAR6
Phase 3 Completed
265 enrolled
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
Phase 3 Completed
1,198 enrolled
Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer
Phase 3 Completed
173 enrolled
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
460 enrolled
BIOPEX
Phase 3 Completed
104 enrolled 8 charts
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer
Phase 3 Completed
598 enrolled
RectumSIB
Phase 3 Completed
156 enrolled
Rektum-III
Phase 3 Completed
401 enrolled
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
2,334 enrolled 9 charts
Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal Cancer
Phase 3 Completed
486 enrolled 13 charts
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Phase 3 Completed
1,691 enrolled
Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease
Phase 3 Completed
67 enrolled
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Phase 3 Completed
1,168 enrolled
ACP
Phase 3 Completed
8,094 enrolled 23 charts
Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer
Phase 3 Completed
336 enrolled
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer
Phase 3 Completed
225 enrolled 12 charts
PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Phase 3 Completed
1,053 enrolled 25 charts
Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer
Phase 3 Completed
6,088 enrolled
NERATEM
Phase 3 Completed
25 enrolled
GRECCAR 2
Phase 3 Completed
148 enrolled
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Phase 3 Completed
847 enrolled 21 charts
CPTD
Phase 3 Completed
200 enrolled
PETACC-6
Phase 3 Completed
1,094 enrolled
Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma
Phase 3 Completed
24 enrolled
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
Phase 3 Completed
2,025 enrolled
Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)
Phase 3 Completed
700 enrolled
Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed
Phase 3 Completed
1,011 enrolled
Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
Phase 3 Completed
264 enrolled
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery
Phase 3 Completed
104 enrolled 15 charts
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer
Phase 3 Completed
1,256 enrolled
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 3 Completed
135 enrolled
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
Phase 3 Completed
141 enrolled
Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer
Phase 3 Completed
88 enrolled
Combination Chemotherapy in Treating Patients With Colorectal Cancer
Phase 3 Completed
400 enrolled
Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Phase 3 Completed
635 enrolled
Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
Phase 3 Completed
762 enrolled